"MILNACIPRAN in Subjects With Chronic Shoulder Pain"

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Chronic Shoulder Pain
Interventions
DRUG

milnacipran

1 tablet (50mg) BID (twice daily, approximately 12 hours apart) for 12 weeks after appropriate titration period

DRUG

Milnacipran

1 tablet (100mg) BID (twice daily, approximately 12 hours apart)for 12 weeks after appropriate titration period.

DRUG

Placebo

1 tablet (placebo) BID (twice daily, approximately 12 hours apart) for 12 weeks after appropriate titration period.

Trial Locations (1)

33484

Delray Research Associates, Delray Beach

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Valera Bussell

INDUSTRY